Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Consensus list of signals to detect potential adverse drug reactions in nursing homes.

Handler SM, Hanlon JT, Perera S, Roumani YF, Nace DA, Fridsma DB, Saul MI, Castle NG, Studenski SA.

J Am Geriatr Soc. 2008 May;56(5):808-15. doi: 10.1111/j.1532-5415.2008.01665.x. Epub 2008 Mar 21.

2.

The Norwegian General Practice--Nursing Home criteria (NORGEP-NH) for potentially inappropriate medication use: A web-based Delphi study.

Nyborg G, Straand J, Klovning A, Brekke M.

Scand J Prim Health Care. 2015 Jun;33(2):134-41. doi: 10.3109/02813432.2015.1041833. Epub 2015 Jun 23.

3.

Assessing the performance characteristics of signals used by a clinical event monitor to detect adverse drug reactions in the nursing home.

Handler SM, Hanlon JT, Perera S, Saul MI, Fridsma DB, Visweswaran S, Studenski SA, Roumani YF, Castle NG, Nace DA, Becich MJ.

AMIA Annu Symp Proc. 2008 Nov 6:278-82.

4.

Adverse drug reaction risk factors in older outpatients.

Hajjar ER, Hanlon JT, Artz MB, Lindblad CI, Pieper CF, Sloane RJ, Ruby CM, Schmader KE.

Am J Geriatr Pharmacother. 2003 Dec;1(2):82-9.

PMID:
15555470
5.

The development and test of an intervention to improve ADR screening in nursing homes.

Dilles T, Vander Stichele RH, Van Bortel LM, Elseviers MM.

J Am Med Dir Assoc. 2013 May;14(5):379.e1-6. doi: 10.1016/j.jamda.2013.02.011. Epub 2013 Apr 2.

PMID:
23557831
6.

Development of a core outcome set for effectiveness trials aimed at optimising prescribing in older adults in care homes.

Millar AN, Daffu-O'Reilly A, Hughes CM, Alldred DP, Barton G, Bond CM, Desborough JA, Myint PK, Holland R, Poland FM, Wright D; CHIPPS Team, University of East Anglia.

Trials. 2017 Apr 12;18(1):175. doi: 10.1186/s13063-017-1915-6.

7.

Dementia and risk of adverse warfarin-related events in the nursing home setting.

Tjia J, Field TS, Mazor KM, Donovan JL, Kanaan AO, Reed G, Doherty P, Harrold LR, Gurwitz JH.

Am J Geriatr Pharmacother. 2012 Oct;10(5):323-30. doi: 10.1016/j.amjopharm.2012.09.003.

PMID:
23063288
8.

Evaluation of nationally mandated drug use reviews to improve patient safety in nursing homes: a natural experiment.

Briesacher B, Limcangco R, Simoni-Wastila L, Doshi J, Gurwitz J.

J Am Geriatr Soc. 2005 Jun;53(6):991-6.

PMID:
15935022
9.

Evaluating the positive predictive values of antidote signals to detect potential adverse drug reactions (ADRs) in the medical intensive care unit (ICU).

Kane-Gill SL, Bellamy CJ, Verrico MM, Handler SM, Weber RJ.

Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1185-91. doi: 10.1002/pds.1837.

PMID:
19728294
10.

Consensus guidelines for oral dosing of primarily renally cleared medications in older adults.

Hanlon JT, Aspinall SL, Semla TP, Weisbord SD, Fried LF, Good CB, Fine MJ, Stone RA, Pugh MJ, Rossi MI, Handler SM.

J Am Geriatr Soc. 2009 Feb;57(2):335-40. doi: 10.1111/j.1532-5415.2008.02098.x. Epub 2008 Dec 10. Erratum in: J Am Geriatr Soc. 2009 Nov;57(11):2179. Dosage error in article text.

11.
12.

Frequency of laboratory monitoring of chronic medications administered to nursing facility residents: results of a national Internet-based study.

Handler SM, Shirts BH, Perera S, Becich MJ, Castle NG, Hanlon JT.

Consult Pharm. 2008 May;23(5):387-95.

13.

Types of medication errors in North Carolina nursing homes: a target for quality improvement.

Hansen RA, Greene SB, Williams CE, Blalock SJ, Crook KD, Akers R, Carey TS.

Am J Geriatr Pharmacother. 2006 Mar;4(1):52-61.

PMID:
16730621
14.

Implementation of a computer-assisted monitoring system for the detection of adverse drug reactions in gastroenterology.

Dormann H, Criegee-Rieck M, Neubert A, Egger T, Levy M, Hahn EG, Brune K.

Aliment Pharmacol Ther. 2004 Feb 1;19(3):303-9.

PMID:
14984377
15.

Effect of a pharmacist-led multicomponent intervention focusing on the medication monitoring phase to prevent potential adverse drug events in nursing homes.

Lapane KL, Hughes CM, Daiello LA, Cameron KA, Feinberg J.

J Am Geriatr Soc. 2011 Jul;59(7):1238-45. doi: 10.1111/j.1532-5415.2011.03418.x. Epub 2011 Jun 7.

16.

Using a Clinical Surveillance System to Detect Drug-Associated Hypoglycemia in Nursing Home Residents.

Culley CM, Perera S, Marcum ZA, Kane-Gill SL, Handler SM.

J Am Geriatr Soc. 2015 Oct;63(10):2125-9. doi: 10.1111/jgs.13648. Epub 2015 Oct 12.

17.

Randomized trial of a warfarin communication protocol for nursing homes: an SBAR-based approach.

Field TS, Tjia J, Mazor KM, Donovan JL, Kanaan AO, Harrold LR, Reed G, Doherty P, Spenard A, Gurwitz JH.

Am J Med. 2011 Feb;124(2):179.e1-7. doi: 10.1016/j.amjmed.2010.09.017.

PMID:
21295198
18.

Epidemiology of medication-related adverse events in nursing homes.

Handler SM, Wright RM, Ruby CM, Hanlon JT.

Am J Geriatr Pharmacother. 2006 Sep;4(3):264-72. Review.

PMID:
17062328
19.

Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey.

Dwyer LL, Han B, Woodwell DA, Rechtsteiner EA.

Am J Geriatr Pharmacother. 2010 Feb;8(1):63-72. doi: 10.1016/j.amjopharm.2010.01.001.

PMID:
20226393
20.

Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions.

Malone DC, Abarca J, Hansten PD, Grizzle AJ, Armstrong EP, Van Bergen RC, Duncan-Edgar BS, Solomon SL, Lipton RB.

J Am Pharm Assoc (2003). 2004 Mar-Apr;44(2):142-51.

PMID:
15098848

Supplemental Content

Support Center